Fatigue in Hemodialysis Patients: A Comparative Analysis with Healthy Controls
Abstract
:1. Introduction
2. Materials and Methods
Statistical Analysis
3. Results
4. Discussion
Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Apostolou, T. (2007). Quality of life in the elderly patients on dialysis. International Urology and Nephrology, 39(2), 679–683. [Google Scholar] [CrossRef] [PubMed]
- Bossola, M., Di Stasio, E., Antocicco, M., Pepe, G., Marzetti, E., & Vulpio, C. (2017). 1-year course of fatigue in patients on chronic hemodialysis. International Urology and Nephrology, 49(4), 727–734. [Google Scholar] [CrossRef]
- Cozart, J., Strober, L., Ruppen, S., Bradish, T., Belcher, C., Louthan, T., Lam, S., Thelen, J., & Bruce, J. (2021). A quick assessment of reliable change in fatigue: Reliable change indices of the modified fatigue impact scale-5 item (MFIS-5). Multiple Sclerosis and Related Disorders, 49, 102743. [Google Scholar] [CrossRef] [PubMed]
- D’Souza, E. (2016). Modified Fatigue Impact Scale-5-item version (MFIS-5). Occupational Medicine, 66(3), 256–257. [Google Scholar] [CrossRef] [PubMed]
- Edwards, D., & Manera, K. (2022). Life participation: When there is more to life than dialysis. Peritoneal Dialysis International, 42(6), 552–553. [Google Scholar] [CrossRef]
- Flythe, J. E., Hilliard, T., Lumby, E., Castillo, G., Orazi, J., Abdel-Rahman, E. M., Pai, A. B., Rivara, M. B., St Peter, W. L., Weisbord, S. D., Wilkie, C. M., Mehrotra, R., & Kidney Health Initiative Prioritizing Symptoms of ESRD Patients for Developing Therapeutic Interventions Stakeholder Meeting Participants. (2019). Fostering innovation in symptom management among hemodialysis patients: Paths forward for insomnia, muscle cramps, and fatigue. Clinical Journal of the American Society of Nephrology, 14(1), 150–160. [Google Scholar] [CrossRef]
- Gembillo, G., Ingrasciotta, Y., Crisafulli, S., Luxi, N., Siligato, R., Santoro, D., & Trifirò, G. (2021). Kidney disease in diabetic patients: From pathophysiology to pharmacological aspects with a focus on therapeutic inertia. International Journal of Molecular Sciences, 22, 4824. [Google Scholar] [CrossRef] [PubMed]
- Gerogianni, G., Babatsikou, F., Polikandrioti, M., & Grapsa, E. (2019). Management of anxiety and depression in haemodialysis patients: The role of non-pharmacological methods. International Urology and Nephrology, 51(1), 113–118. [Google Scholar] [CrossRef]
- Horigan, A. E. (2012). Fatigue in hemodialysis patients: A review of current knowledge. Journal of Pain and Symptom Management, 44(5), 715–724. [Google Scholar] [CrossRef]
- Horigan, A. E., & Barroso, J. V. (2016). A comparison of temporal patterns of fatigue in patients on hemodialysis. Nephrology Nursing Journal, 43(2), 129–138, 148; quiz 139. [Google Scholar] [PubMed] [PubMed Central]
- Jordakieva, G., Grabovac, I., Steiner, M., Winnicki, W., Zitta, S., Stefanac, S., Brooks, M., Sunder-Plaßmann, G., Rosenkranz, A. R., & Godnic-Cvar, J. (2020). Employment status and associations with workability, quality of life and mental health after kidney transplantation in Austria. International Journal of Environmental Research and Public Health, 17(4), 1254. [Google Scholar] [CrossRef]
- Ju, A., Unruh, M. L., Davison, S. N., Dapueto, J., Dew, M. A., Fluck, R., Germain, M., Jassal, S. V., Obrador, G., O’Donoghue, D., Tugwell, P., Craig, J. C., Ralph, A. F., Howell, M., & Tong, A. (2018). Patient-reported outcome measures for fatigue in patients on hemodialysis: A systematic review. American Journal of Kidney Diseases, 71(3), 327–343. [Google Scholar] [CrossRef]
- Karadag, E., Kilic, S. P., & Metin, O. (2013). Relationship between fatigue and social support in hemodialysis patients. Nursing & Health Sciences, 15(2), 164–171. [Google Scholar] [CrossRef]
- Karava, V., Goutou, S., Dotis, J., Kondou, A., Charela, E., Dadoudi, O., Eleftheriadis, T., Stefanidis, I., & Printza, N. (2022). Fatigue and quality of life in children with chronic kidney disease. Children, 9(9), 1414. [Google Scholar] [CrossRef]
- Kefale, B., Alebachew, M., Tadesse, Y., & Engidawork, E. (2019). Quality of life and its predictors among patients with chronic kidney disease: A hospital-based cross sectional study. PLoS ONE, 14(2), e0212184. [Google Scholar] [CrossRef]
- Kraus, M. A., Fluck, R. J., Weinhandl, E. D., Kansal, S., Copland, M., Komenda, P., & Finkelstein, F. O. (2016). Intensive hemodialysis and health-related quality of life. American Journal of Kidney Diseases, 68(5S1), S33–S42. [Google Scholar] [CrossRef] [PubMed]
- Krawczyk-Suszek, M., Gaweł, A., & Kleinrok, A. (2024). Ranking of diseases affecting the health-related quality of life of patients in Poland—A cross-sectional study. Archives of Medical Science, 20(5), 1567–1578. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Kušleikaitė, N., Bumblytė, I. A., Kuzminskis, V., & Vaičiūnienė, R. (2010). The association between health-related quality of life and mortality among hemodialysis patients. Medicina, 46(8), 531–537. [Google Scholar] [CrossRef] [PubMed]
- Meca-Lallana, V., Brañas-Pampillón, M., Higueras, Y., Candeliere-Merlicco, A., Aladro-Benito, Y., la Fuente, O. R., Salas-Alonso, E., Maurino, J., & Ballesteros, J. (2019). Assessing fatigue in multiple sclerosis: Psychometric properties of the five-item Modified Fatigue Impact Scale (MFIS-5). Multiple Sclerosis Journal—Experimental, Translational and Clinical, 5(4), 2055217319887987. [Google Scholar] [CrossRef]
- Pojatić, Đ., Nikić, D., Tolj, I., Pezerović, D., Šantić, A., & Degmečić, D. (2022). Alexithymia, phosphorus levels, and sleep disorders in patients on hemodialysis. Journal of Clinical Medicine, 11(11), 3218. [Google Scholar] [CrossRef]
- Sakiqi, J., Vasilopoulos, G., Koutelekos, I., Polikandrioti, M., Dousis, E., Pavlatou, N., Kalogianni, A., Tsirigotis, S., & Gerogianni, G. (2022). Depression among hemodialysis patients: Related factors and the impact of insomnia and fatigue. Cureus, 14(5), e25254. [Google Scholar] [CrossRef]
- Skevington, S., Lotfy, M., O’Connell, K. A., & WHOQOL Group. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13(2), 299–310. [Google Scholar] [CrossRef] [PubMed]
- Sousa, H., Ribeiro, O., Paúl, C., Costa, E., Miranda, V., Ribeiro, F., & Figueiredo, D. (2019). Social support and treatment adherence in patients with end-stage renal disease: A systematic review. Seminars in Dialysis, 32(6), 562–574. [Google Scholar] [CrossRef] [PubMed]
- Sułkowski, L., Matyja, A., & Matyja, M. (2024). Social support and quality of life in hemodialysis patients: A comparative study with healthy controls. Medicina, 60(11), 1732. [Google Scholar] [CrossRef] [PubMed]
- Sułkowski, L., Matyja, A., & Matyja, M. (2025). The Impact of dialysis duration on multidimensional health outcomes: A cross-sectional study. Journal of Clinical Medicine, 14(2), 376. [Google Scholar] [CrossRef] [PubMed]
- Sułkowski, L., Matyja, M., Pasternak, A., & Matyja, A. (2018). WHOQOL-BREF survey of quality of life among dialyzed end-stage renal disease patients. Archives of Medical Science—Civilization Diseases, 3(1), 112–120. [Google Scholar] [CrossRef]
- Sułkowski, L., Rubinkiewicz, M., Matyja, A., & Matyja, M. (2023). Visual impairment in hemodialyzed patients—An IVIS study. Medicina, 59, 1106. [Google Scholar] [CrossRef] [PubMed]
- Szabo, S. (1996). The World Health Organization Quality of Life (WHOQOL) assessment instrument. In B. Spiker (Ed.), Quality of life and pharmacoeconomics in clinical trials (pp. 355–362). Lippincott-Raven. [Google Scholar]
- The WHOQOL Group. (1998a). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551–558. [Google Scholar] [CrossRef]
- The WHOQOL Group. (1998b). The World Health Organization Quality of Life Assessment (WHOQOL): Development and general psychometric properties. Social Science & Medicine, 46(12), 1569–1585. [Google Scholar] [CrossRef]
- Theofilou, P. (2011). Quality of life in patients undergoing hemodialysis or peritoneal dialysis treatment. Journal of Clinical Medicine Research, 3(3), 132–138. [Google Scholar] [CrossRef]
- Tsirigotis, S., Polikandrioti, M., Alikari, V., Dousis, E., Koutelekos, I., Toulia, G., Pavlatou, N., I Panoutsopoulos, G., Leftheriotis, D., & Gerogianni, G. (2022). Factors associated with fatigue in patients undergoing hemodialysis. Cureus, 14(3), e22994. [Google Scholar] [CrossRef]
- Wolfgram, D. F. (2019). Intradialytic cerebral hypoperfusion as mechanism for cognitive impairment in patients on hemodialysis. Journal of the American Society of Nephrology, 30(11), 2052–2058. [Google Scholar] [CrossRef] [PubMed]
- Zazzeroni, L., Pasquinelli, G., Nanni, E., Cremonini, V., & Rubbi, I. (2017). Comparison of quality of life in patients undergoing hemodialysis and peritoneal dialysis: A systematic review and meta-analysis. Kidney and Blood Pressure Research, 42(4), 717–727. [Google Scholar] [CrossRef] [PubMed]
Questionnaires | MFIS | WHOQOL-BREF | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
MFIS Total Score | 5-Item MFIS-5 Score | Physical Subscale | Cognitive Subscale | Psychosocial Subscale | Physical health Domain | Psychological health Domain | Social Relationship Domain | Environment Domain | ||
sex | HD male | 40.7 (18.5) | 10.4 (4.6) | 21.1 (8.9) | 15.1 (8.7) | 4.5 (2.3) | 12.0 (1.6) | 12.7 (2.2) | 13.2 (3.2) | 13.7 (2.3) |
healthy male | 22.1 (19.2) | 6.0 (4.1) | 9.8 (8.6) | 9.9 (8.9) | 2.4 (2.3) | 13.9 (1.3) | 15.0 (2.1) | 13.3 (3.4) | 15.5 (3.2) | |
HD vs. healthy male p-value | <0.0001 | <0.0001 | <0.0001 | 0.0001 | <0.0001 | <0.0001 | <0.0001 | N/S | <0.002 | |
HD female | 36.3 (17.9) | 9.9 (4.3) | 18.6 (8.8) | 13.4 (8.2) | 4.4 (2.3) | 12.0 (2.2) | 12.6 (2.2) | 13.6 (3.1) | 13.6 (2.3) | |
healthy female | 35.1 (17.4) | 8.7 (4.0) | 15.8 (8.2) | 15.8 (7.8) | 3.5 (2.0) | 12.6 (1.6) | 13.4 (1.9) | 13.9 (3.1) | 13.2 (2.0) | |
HD vs. healthy female p-value | N/S | N/S | N/S | N/S | N/S | N/S | N/S | N/S | N/S | |
age | <median | 33.2 (16.9) | 8.8 (4.6) | 17.5 (8.9) | 11.9 (7.3) | 3.7 (2.3) | 12.2 (1.9) | 12.8 (2.2) | 13.4 (3.4) | 13.5 (2.5) |
>median | 45.4 (17.9) | 11.6 (4.1) | 23.0 (8.1) | 7.1 (9.0) | 5.2 (2.1) | 11.9 (2.0) | 12.7 (2.1) | 13.7 (2.9) | 13.9 (2.2) | |
p-value | <0.002 | <0.002 | <0.001 | 0.003 | 0.0005 | N/S | N/S | N/S | N/S | |
education | primary | 40.8 (21.3) | 10.0 (5.2) | 20.5 (9.9) | 15.8 (9.7) | 4.4 (2.6) | 11.8 (1.8) | 12.7 (2.3) | 13.5 (3.5) | 13.3 (2.2) |
secondary | 38.6 (11.9) | 10.8 (3.1) | 20.5 (6.9) | 13.4 (6.0) | 4.7 (1.8) | 11.7 (1.8) | 12.8 (2.1) | 13.7 (2.8) | 13.6 (2.0) | |
university | 35.3 (16.9) | 9.9 (4.2) | 19.0 (8.5) | 11.9 (7.8) | 4.4 (1.8) | 13.1 (1.5) | 13.1 (2.0) | 13.9 (2.4) | 15.3 (1.9) | |
p-value | N/S | N/S | N/S | N/S | N/S | 0.0003 a 0.0002 b | N/S | N/S | <0.002 a 0.0004 b | |
marital status | married | 40.0 (17.1) | 10.5 (4.0) | 21.0 (7.8) | 14.5 (8.6) | 4.5 (2.1) | 12.2 (2.0) | 12.9 (2.1) | 13.8 (3.0) | 13.9 (2.3) |
single | 37.8 (20.7) | 9.6 (5.4) | 18.8 (10.6) | 14.7 (8.5) | 4.4 (2.7) | 11.8 (1.3) | 12.5 (2.3) | 13.2 (3.6) | 13.3 (2.1) | |
p-value | N/S | N/S | N/S | N/S | N/S | N/S | N/S | N/S | N/S |
Questionnaires | MFIS | WHOQOL-BREF | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
MFIS Total Score | 5-Item MFIS-5 Score | Physical Subscale | Cognitive Subscale | Psychosocial Subscale | Physical health Domain | Psychological health Domain | Social Relationship Domain | Environment Domain | ||
duration of the hemodialysis session | <4 h | 37.8 (18.4) | 9.7 (4.7) | 19.4 (9.8) | 13.8 (7.0) | 4.6 (2.6) | 12.4 (1.9) | 13.1 (2.4) | 14.7 (3.4) | 14.1 (2.0) |
>4 h | 32.6 (20.1) | 8.2 (5.0) | 17.0 (9.9) | 12.7 (9.3) | 2.9 (2.2) | 11.9 (1.7) | 12.8 (1.9) | 12.8 (2.7) | 14.0 (1.9) | |
p-value | N/S | N/S | N/S | N/S | 0.0002 | N/S | N/S | <0.002 | N/S | |
Kt/V | <median | 38.3 (19.9) | 10.4 (4.6) | 20.6 (9.6) | 13.6 (9.6) | 4.1 (2.2) | 12.2 (1.6) | 13.2 (1.9) | 13.9 (2.7) | 14.1 (2.0) |
>median | 40.8 (16.4) | 10.2 (4.4) | 20.2 (8.1) | 15.7 (7.2) | 4.9 (2.3) | 11.9 (2.0) | 12.3 (2.3) | 13.2 (3.5) | 13.3 (2.4) | |
p-value | N/S | N/S | N/S | N/S | N/S | N/S | N/S | N/S | N/S | |
vascular access | AVF | 39.3 (17.9) | 10.3 (4.3) | 20.4 (8.6) | 14.4 (8.5) | 4.5 (2.3) | 12.0 (1.8) | 12.8 (2.2) | 13.6 (3.0) | 13.7 (2.2) |
CVC | 39.7 (22.0) | 9.7 (6.2) | 19.7 (11.2) | 15.6 (8.9) | 4.4 (2.5) | 12.5 (1.7) | 12.4 (1.9) | 13.3 (3.7) | 13.5 (2.5) | |
p-value | N/S | N/S | N/S | N/S | N/S | N/S | N/S | N/S | N/S | |
URR | <median | 40.8 (20.7) | 10.8 (4.8) | 21.4 (10.0) | 14.9 (9.9) | 4.4 (2.4) | 12.0 (1.6) | 13.0 (2.1) | 13.6 (3.1) | 13.8 (2.1) |
>median | 38.0 (15.7) | 9.6 (4.2) | 19.3 (7.5) | 14.2 (7.1) | 4.5 (2.2) | 12.1 (2.0) | 12.5 (2.1) | 13.5 (3.1) | 13.7 (2.3) | |
p-value | N/S | N/S | N/S | N/S | N/S | N/S | N/S | N/S | N/S |
Hemodialyzed Patients | Healthy Controls | ||||
---|---|---|---|---|---|
Scoring Range | n/M [Range] (SD) | n/M [Range] (SD) | p-Value | ||
sex | male | 79 (68.7%) | 76 (67.9%) | N/S | |
female | 36 (31.3%) | 36 (32.1%) | N/S | ||
age | 63.7 [31–86] (11.5) | 60.6 [30–73] (11.9) | N/S | ||
Modified Fatigue Impact Scale (MFIS) | MFIS (full scale) | 0–84 | 39.3 (18.3) | 29.6 (19.1) | <0.0001 |
MFIS-5 (5-item version) | 0–20 | 10.2 (4.5) | 7.6 (4.2) | <0.0001 | |
Physical Subscale | 0–36 | 20.3 (8.9) | 13.3 (8.7) | <0.0001 | |
Cognitive Subscale | 0–40 | 14.5 (8.5) | 13.3 (8.7) | N/S | |
Psychosocial Subscale | 0–8 | 4.5 (2.3) | 3.0 (2.2) | <0.0001 | |
World Health Organization Quality of Life questionnaire (WHOQOL-BREF) | Physical health domain | 4–20 | 11.9 (1.7) | 13.3 (1.6) | <0.0001 |
Psychological health domain | 4–20 | 12.6 (2.1) | 14.5 (1.9) | <0.0001 | |
Social relationship domain | 4–20 | 13.5 (3.1) | 13.8 (3.4) | N/S | |
Environment domain | 4–20 | 13.8 (2.3) | 14.0 (2.5) | N/S |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Published by MDPI on behalf of the University Association of Education and Psychology. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sułkowski, L.; Matyja, A.; Matyja, M. Fatigue in Hemodialysis Patients: A Comparative Analysis with Healthy Controls. Eur. J. Investig. Health Psychol. Educ. 2025, 15, 12. https://doi.org/10.3390/ejihpe15020012
Sułkowski L, Matyja A, Matyja M. Fatigue in Hemodialysis Patients: A Comparative Analysis with Healthy Controls. European Journal of Investigation in Health, Psychology and Education. 2025; 15(2):12. https://doi.org/10.3390/ejihpe15020012
Chicago/Turabian StyleSułkowski, Leszek, Andrzej Matyja, and Maciej Matyja. 2025. "Fatigue in Hemodialysis Patients: A Comparative Analysis with Healthy Controls" European Journal of Investigation in Health, Psychology and Education 15, no. 2: 12. https://doi.org/10.3390/ejihpe15020012
APA StyleSułkowski, L., Matyja, A., & Matyja, M. (2025). Fatigue in Hemodialysis Patients: A Comparative Analysis with Healthy Controls. European Journal of Investigation in Health, Psychology and Education, 15(2), 12. https://doi.org/10.3390/ejihpe15020012